Patents by Inventor Sandrine Belouzard

Sandrine Belouzard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND AND METHOD FOR THE TREATMENT OF CORONAVIRUSES
    Publication number: 20230233483
    Abstract: The disclosure relates to the use of clofoctol in the prevention or treatment of a disease caused by a coronavirus, in particular Covid-19.
    Type: Application
    Filed: June 8, 2021
    Publication date: July 27, 2023
    Applicants: Apteeus, Universite De Lille, Centre National De La Recherche Scientifique, Institut National De La Sante Et De La Recherche Medicale, Centre Hospitalier Universitaire De Lille
    Inventors: Terence Beghyn, Benoît Deprez, Sandrine Belouzard, Priscille Brodin
  • LEPROTL1 and OB-RGRP genes for screening compounds that act on the gain or loss of weight or on diabetes in a human or animal subject
    Publication number: 20060068429
    Abstract: A method for identifying compounds acting on weight gain or weight loss or on diabetes in a human or animal subject including measuring effect of the compounds on (a) expression of at least one of genes LEPROTL1 and OB-RGRP or a part of them and/or (b) intracellular transport up to a cellular membrane and/or (c) presence at the cellular membrane level and/or (d) internalization from the membrane of proteins coded by at least one of these genes or part of them.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 30, 2006
    Applicant: Centre National de la Recherche Scientifique - CNRS, an organization of France
    Inventors: Bernard Bailleul, Yves Rouille, Karin Seron, Sandrine Belouzard